EA
STAA icon

Evolution Advisers’s STAAR Surgical STAA Stock Holding History

Evolution Advisers’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+4
New +$111 ﹤0.01% 807

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Evolution Advisers's STAA Position: Q2 2026 in Review

Evolution Advisers opened a new position in STAAR Surgical (STAA) in Q2 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #807 among its holdings.

200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Evolution Advisers held 4 shares of STAAR Surgical worth $0 as of Q2 2026.
  • STAAR Surgical was a new Evolution Advisers position in Q2 2026.
  • STAAR Surgical made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #807 holding.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.